GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Outperform
RMD
up 138.23 %

Resmed Inc. (RMD) rated Outperform with price target $50 by BMO Capital Markets

Posted on: Friday,  Feb 8, 2008  9:25 AM ET by BMO Capital Markets

BMO Capital Markets rated Outperform Resmed Inc. (NYSE: RMD) on 02/08/2008, when the stock price was $21.68. Since
then, Resmed Inc. has gained 138.24% as of 01/22/2016's recent price of $51.65.
If you would have followed this BMO Capital Markets's recommendation on RMD, you would have gained 138.23% of your investment in 2905 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/8/2008 9:25 AM Buy
None
21.68 25.00
as of 12/24/2008
1 Week down  -1.02 %
1 Month up  18.66 %
3 Months down  -3.35 %
1 YTD down  -6.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy